注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Genenta Science SpA是一家意大利的公司,从事临床阶段的生物技术研究。该公司专注于开发基于慢病毒基因和细胞疗法治疗癌症。它使用基于基因细胞因子传递来激活肿瘤内的免疫系统,提供抗肿瘤反应。该公司不仅在本地开展业务,也在包括美国在内的全球市场开展业务。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Pierluigi Paracchi | 51 | 2014 | Vice Chairman of the Board, CEO & GM |
Bernard Rudolph Gentner | 49 | - | Co-Founder & Member of the Executive Scientific Board |
Luigi Naldini | 65 | - | Co-Founder & Chairman of the Executive Scientific Board |
Miriam Merad | - | 2021 | Member of Scientific Advisory Board |
Wolf-Herve Fridman | - | 2021 | Member of Scientific Advisory Board |
Richard A. Flavell | 78 | 2021 | Member of Scientific Advisory Board |
Carlo-Alberto Nicchio | 49 | 2021 | Chairman of the Board of Statutory Auditors |
Michele De Palma | - | - | Member of Scientific Advisory Board |
Lisa M. Coussens | - | - | Member of Scientific Advisory Board |
Kenneth C. Anderson | 73 | - | Member of Scientific Advisory Board |
Jacopo Doveri | 51 | 2021 | Statutory Auditor |
Patrick Yung Wen | - | 2021 | Member of Scientific Advisory Board |
Cesare Lazzaroni | 73 | 2021 | Statutory Auditor |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核